Krs Capital Management, LLC Eli Lilly & CO Transaction History

Krs Capital Management, LLC

$137 Million
Q3 2024

A detailed history of Krs Capital Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Krs Capital Management, LLC holds 4,750 shares of LLY stock, worth $3.77 Million. This represents 3.08% of its overall portfolio holdings.

Number of Shares

4,750

Previous 4,770 0.42%

Holding current value

$3.77 Million

Previous $4.32 Million 2.55%

% of portfolio

3.08%

Previous 3.24%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$772.14 - $960.02 $15,442 - $19,200	-20 Reduced 0.42%	4,750 $4.21 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $11,597 - $14,544	16 Added 0.34%	4,770 $4.32 Million
Q1 2024 Apr 16, 2024	SELL	$592.2 - $792.28 $139,167 - $186,185	-235 Reduced 4.71%	4,754 $3.7 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $105,563 - $124,445	201 Added 4.2%	4,989 $2.91 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $24,777 - $34,160	57 Added 1.2%	4,788 $2.57 Million
Q2 2023 Jul 14, 2023	BUY	$350.74 - $468.98 $7,716 - $10,317	22 Added 0.47%	4,731 $2.22 Million
Q1 2023 Apr 11, 2023	BUY	$310.63 - $364.82 $137,609 - $161,615	443 Added 10.38%	4,709 $1.62 Million
Q4 2022 Jan 19, 2023	BUY	$321.55 - $374.67 $94,214 - $109,778	293 Added 7.37%	4,266 $0
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $255,269 - $290,906	861 Added 27.67%	3,973 $1.28 Million
Q2 2022 Aug 02, 2022	BUY	$278.73 - $327.27 $7,525 - $8,836	27 Added 0.88%	3,112 $1.01 Million
Q1 2022 Apr 27, 2022	BUY	$234.69 - $291.66 $469 - $583	2 Added 0.06%	3,085 $883,000
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $693,212 - $860,280	3,083 New	3,083 $851,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $755B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Krs Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Krs Capital Management, LLC with notifications on news.

Account

Krs Capital Management, LLC Eli Lilly & CO Transaction History